Intriguingly, a recent study has demonstrated how metabolic changes in myeloma cells can drive reciprocal changes in bone cells, with glutamine consumption by myeloma cells resulting in an increase in glutamine synthetase in bone marrow stromal cells, and an inhibition of their osteoblastic differentiation [45••]. This evidence concerns the gene GLUL and plasma cell myeloma.